🔗 Permalink

Inventor profile of:

Orrin Devinsky

City:

New York, New York

Country:

United States

Published Applications:

Last publication date:

2025-11-13

Top Assignees for applications by Orrin Devinsky

The entities that hold a legal rights for patent applications filed by inventor Devinsky Orrin:

GW Research Limited 17 Cambridge, United Kingdom
GW Pharma Limited 5 Cambridge, United Kingdom
Jazz Pharmaceuticals Research UK Limited 2 Sittingbourne, United Kingdom
GW Pharma Limited 2 Vision Park, Histon, Cambridge, -
Jazz Pharmaceuticals Research UK Limited 1 Kent, United Kingdom
GW Pharma Limited 1 Vision Park, Histon, Cambridge, United Kingdom
President and Fellows of Harvard College 1 Cambridge, MA United States
THE BROAD INSTITUTE, INC. 1 Cambridge, MA United States
NEW YORK UNIVERSITY 1 New York, NY United States

Recent patent applications by Devinsky Orrin

Orrin Devinsky from New York, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-13

US20250345349A1

Human necessities

CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#2 | 2025-08-07

US20250248950A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#3 | 2024-10-24

US20240350428A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#4 | 2024-08-08

US20240261234A1

Human necessities

USE OF CANNABIDIOL IN THE TREATMENT OF NOCTURNAL SNORING

#5 | 2024-05-23

US20240165048A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#6 | 2023-09-28

US20230301936A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#7 | 2023-08-10

US20230248664A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#8 | 2023-03-02

US20230069642A1

Chemistry; metallurgy

PRECISE TEMPLATE-FREE CORRECTION OF BRCA1 MUTATION IN HUMAN CELLS VIA GENOME EDITING

#9 | 2023-02-02

US20230032502A1

Human necessities

USE OF CANNABIDIOL IN THE TREATMENT OF NOCTURNAL SNORING

#10 | 2022-12-15

US20220395471A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#11 | 2022-12-08

US20220387348A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#12 | 2022-12-01

US20220378717A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#13 | 2022-11-24

US20220370805A1

Human necessities

ELECTROENCEPHALOGRAPHY (EEG) ELECTRODE ARRAYS AND RELATED METHODS OF USE

#14 | 2022-06-30

US20220202738A1

Human necessities

CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#15 | 2022-06-23

US20220195457A1

Chemistry; metallurgy

INTERNEURON-SPECIFIC THERAPEUTICS FOR NORMALIZING NEURONAL CELL EXCITABILITY AND TREATING DRAVET SYNDROME

#16 | 2022-01-06

US20220000800A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#17 | 2021-12-30

US20210401771A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#18 | 2021-10-28

US20210330636A1

Human necessities

USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY

#19 | 2021-08-12

US20210244685A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#20 | 2021-07-01

US20210196651A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#21 | 2021-04-01

US20210093581A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#22 | 2020-11-26

US20200368179A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#23 | 2020-10-15

US20200323792A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#24 | 2020-09-24

US20200297656A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#25 | 2020-06-11

US20200179303A1

Human necessities

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#26 | 2020-03-05

US20200069608A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#27 | 2020-01-02

US20200000741A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#28 | 2019-03-28

US20190091171A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#29 | 2018-12-13

US20180355432A1

Chemistry; metallurgy

IDENTIFICATION OF EPILEPSY PATIENTS AT INCREASED RISK FROM SUDDEN UNEXPECTED DEATH IN EPILEPSY

#30 | 2018-11-29

US20180338931A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#31 | 2017-09-21

US20170266126A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#32 | 2017-08-24

US20170239193A1

Human necessities

USE OF CANNABIDIOL IN THE TREATMENT OF NOCTURNAL SNORING

#33 | 2017-08-17

US20170231923A1

Human necessities

Use of cannabidiol in the treatment of epilepsy

#34 | 2017-06-29

US20170181982A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#35 | 2017-06-22

US20170173044A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#36 | 2017-06-22

US20170173043A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#37 | 2017-06-22

US20170172941A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#38 | 2017-06-22

US20170172940A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#39 | 2017-06-22

US20170172939A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#40 | 2017-01-12

US20170007551A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#41 | 2016-06-16

US20160166515A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

#42 | 2015-12-17

US20150359756A1

Human necessities

Use of cannabinoids in the treatment of epilepsy

InventorID:

1390611 ⎘